PARIANO, MARILENA
 Distribuzione geografica
Continente #
NA - Nord America 1.171
EU - Europa 805
AS - Asia 531
AF - Africa 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.516
Nazione #
US - Stati Uniti d'America 1.166
IT - Italia 311
IE - Irlanda 239
SG - Singapore 219
HK - Hong Kong 136
CN - Cina 91
VN - Vietnam 46
DE - Germania 42
RO - Romania 32
RU - Federazione Russa 24
SE - Svezia 24
FI - Finlandia 23
FR - Francia 21
GB - Regno Unito 20
BE - Belgio 14
AT - Austria 13
KR - Corea 12
UA - Ucraina 11
NL - Olanda 9
CH - Svizzera 7
CZ - Repubblica Ceca 7
TR - Turchia 7
CA - Canada 5
JP - Giappone 5
PH - Filippine 5
GR - Grecia 4
IN - India 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
AU - Australia 2
BG - Bulgaria 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
Totale 2.516
Città #
Chandler 274
Dublin 232
Singapore 183
Hong Kong 135
Perugia 113
Boardman 97
San Mateo 71
Santa Clara 68
Ann Arbor 67
Altamura 52
Dong Ket 46
Medford 42
Princeton 42
Lawrence 40
Wilmington 31
Andover 27
Bucharest 25
Des Moines 21
Beijing 19
Dearborn 16
Helsinki 16
Los Angeles 15
Brussels 14
Munich 11
Rome 11
Vienna 11
Redmond 10
Norwalk 9
Seoul 9
Woodbridge 9
Falls Church 8
San Paolo di Civitate 8
Ashburn 7
Camerino 7
Brno 6
Kocaeli 6
Redwood City 6
Santarcangelo di Romagna 6
Shenzhen 6
Bologna 5
Chicago 5
Milan 5
Saint Petersburg 5
Verona 5
Cambridge 4
Dallas 4
Macerata 4
Shanghai 4
Spin 4
Timisoara 4
Turin 4
Abidjan 3
Amsterdam 3
Chiajna 3
Deruta 3
Florence 3
Fremont 3
Guangzhou 3
Houston 3
Lappeenranta 3
Nanjing 3
Naples 3
Osaka 3
Pioltello 3
Chengdu 2
Chennai 2
Collazzone 2
Den Haag 2
Dong-gu 2
Edinburgh 2
Frankfurt am Main 2
Groningen 2
Hangzhou 2
Hefei 2
Jamaica Plain 2
Monreale 2
Morrovalle 2
Nanning 2
Nürnberg 2
Ottawa 2
Palermo 2
Paris 2
Prata Di Pordenone 2
San Daniele del Friuli 2
Sindelfingen 2
Terracina 2
Tokyo 2
Toronto 2
Xi'an 2
Zhengzhou 2
Angeles City 1
Aprilia 1
Arezzo 1
Birmingham 1
Boydton 1
Böblingen 1
Cairo 1
Castel Maggiore 1
Changzhou 1
Chongqing 1
Totale 1.930
Nome #
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 112
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis 89
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra 84
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 80
Cellular proteostasis: a new twist in the action of thymosin α1 79
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 68
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 67
Microbes in the Era of Circadian Medicine 64
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 64
Tryptophan Co-Metabolism at the Host-Pathogen Interface 60
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis 59
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. 57
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 57
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease 57
Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome 55
Circadian Regulation of Xenobiotic Metabolism during Anticancer Treatment 54
Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection 54
The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways 53
Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity 52
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 52
Defective Glyoxalase 1 Contributes to Pathogenic Inflammation in Cystic Fibrosis 52
To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease 51
Selectively targeting key inflammatory pathways in cystic fibrosis 51
Thymosin α1 protects from CTLA-4 intestinal immunopathology 51
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting 51
The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface 50
Leucine-rich repeat kinase 2 controls the Ca2+/nuclear factor of activated T Cells/IL-2 pathway during Aspergillus non-canonical autophagy in dendritic cells 49
Thymosin alpha 1 in cystic fibrosis: from the lung to the gut 47
Tryptophan as a Central Hub for Host/Microbial Symbiosis 46
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk 44
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis 44
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 43
A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis 42
A Reappraisal of Thymosin Alpha1 in Cancer Therapy 41
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 41
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation 41
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis 40
A shifted composition of the lung microbiota conditions the antifungal response of immunodeficient mice 40
The microbiota/host immune system interaction in the nose to protect from COVID-19 39
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 38
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line 37
Thymosin β4 limits inflammation through autophagy 36
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity 32
Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis 28
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis 27
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 26
The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections 25
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 24
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections 23
Small molecule ccr4 antagonists protect mice from aspergillus infection and allergy 23
Biologics, Theranostics, and Personalized Medicine in Drug Delivery Systems 22
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells 22
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 16
Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines 16
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems 16
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia 15
Commensal fungi and oxalate degradation: is there a link? 14
The immune and microbial homeostasis determines the Candida–mast cells cross-talk in celiac disease 14
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 13
SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome 10
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 10
Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches 9
Bacteria and fungi of the lung: allies or enemies? 7
Unity Is Strength: The Mutual Alliance between CFTR and SLC26A6 as Therapeutic Opportunity in Cystic Fibrosis 5
Host-microbe serotonin metabolism 4
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models 3
Totale 2.695
Categoria #
all - tutte 14.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 0 18 3 10 23 10 6 3
2020/2021210 0 16 6 0 56 3 21 13 19 20 5 51
2021/2022419 7 64 9 20 25 8 17 92 13 24 76 64
2022/2023909 48 170 13 69 109 88 7 46 319 4 30 6
2023/2024489 28 57 18 16 26 4 118 7 37 16 79 83
2024/2025467 22 89 31 101 138 86 0 0 0 0 0 0
Totale 2.695